Shares Outstanding Shares Outstanding n/a Close	36.19M
Shares Change (YoY) Shares Change (YoY) n/a Close	0.08%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	0%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	3.84%
Shares Floating Shares Floating n/a Close	10.79M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	3,544
FTD / Avg. Volume FTD / Avg. Volume n/a Close	1.41%

Short Selling Information

The latest short interest is 178.81K, so 0.49% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	178.81K
Short % of Shares Out Short % of Shares Out n/a Close	0.49%
Short % of Float Short % of Float n/a Close	1.69%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1

Valuation Ratios

The PE ratio is -3.54 and the forward PE ratio is -2.53. Armata Pharmaceuticals's PEG ratio is 0.05.

PE Ratio PE Ratio n/a Close	-3.54
Forward PE Forward PE n/a Close	-2.53
PS Ratio PS Ratio n/a Close	12.93
Forward PS Forward PS n/a Close	1.2
PB Ratio PB Ratio n/a Close	-1.39
P/FCF Ratio P/FCF Ratio n/a Close	-1.7
PEG Ratio PEG Ratio n/a Close	0.05

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Armata Pharmaceuticals.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 0.23, with a Debt / Equity ratio of -2.63.

Current Ratio Current Ratio n/a Close	0.23
Quick Ratio Quick Ratio n/a Close	0.23
Debt / Equity Debt / Equity n/a Close	-2.63
Debt / EBITDA Debt / EBITDA n/a Close	-18.47
Debt / FCF Debt / FCF n/a Close	-3.21
Interest Coverage Interest Coverage n/a Close	-3.95

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$86,233.33
Profits Per Employee Profits Per Employee n/a Close	$-315,266.67
Employee Count Employee Count n/a Close	60
Asset Turnover Asset Turnover n/a Close	0.06
Inventory Turnover Inventory Turnover n/a Close	n/a

Taxes

Income Tax Income Tax n/a Close	n/a
Effective Tax Rate Effective Tax Rate n/a Close	0%

Stock Price Statistics

The stock price has increased by -33.45% in the last 52 weeks. The beta is 0.97, so Armata Pharmaceuticals's price volatility has been higher than the market average.

Beta Beta n/a Close	0.97
52-Week Price Change 52-Week Price Change n/a Close	-33.45%
50-Day Moving Average 50-Day Moving Average n/a Close	1.66
200-Day Moving Average 200-Day Moving Average n/a Close	1.99
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	51.07
Average Volume (20 Days) Average Volume (20 Days) n/a Close	251,082

Income Statement

In the last 12 months, Armata Pharmaceuticals had revenue of 5.17M and earned -18.92M in profits. Earnings per share was -0.52.

Revenue Revenue n/a Close	5.17M
Gross Profit Gross Profit n/a Close	3.85M
Operating Income Operating Income n/a Close	-42.44M
Net Income Net Income n/a Close	-18.92M
EBITDA EBITDA n/a Close	-6.85M
EBIT EBIT n/a Close	-8.17M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-0.52

Full Income Statement

Balance Sheet

The company has 9.29M in cash and 126.52M in debt, giving a net cash position of -117.22M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	9.29M
Total Debt Total Debt n/a Close	126.52M
Net Cash Net Cash n/a Close	-117.22M
Retained Earnings Retained Earnings n/a Close	-327.74M
Total Assets Total Assets n/a Close	87.25M
Working Capital Working Capital n/a Close	-97.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.55M and capital expenditures -1.88M, giving a free cash flow of -39.43M.

Operating Cash Flow Operating Cash Flow n/a Close	-37.55M
Capital Expenditures Capital Expenditures n/a Close	-1.88M
Free Cash Flow Free Cash Flow n/a Close	-39.43M
FCF Per Share FCF Per Share n/a Close	-1.09

Full Cash Flow Statement

Margins

Gross margin is 74.39%, with operating and profit margins of -820.18% and -365.6%.

Gross Margin Gross Margin n/a Close	74.39%
Operating Margin Operating Margin n/a Close	-820.18%
Pretax Margin Pretax Margin n/a Close	-365.6%
Profit Margin Profit Margin n/a Close	-365.6%
EBITDA Margin EBITDA Margin n/a Close	-132.37%
EBIT Margin EBIT Margin n/a Close	-820.18%
FCF Margin FCF Margin n/a Close	-762.08%

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for ARMP is $9, which is 386.5% higher than the current price. The consensus rating is "Strong Buy".

Price Target Price Target n/a Close	$9
Price Target Difference Price Target Difference n/a Close	386.5%
Analyst Consensus Analyst Consensus n/a Close	Strong Buy
Analyst Count Analyst Count n/a Close	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:14.

Last Split Date Last Split Date n/a Close	May 10, 2019
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:14

Scores

Altman Z-Score Altman Z-Score n/a Close	-5.8
Piotroski F-Score Piotroski F-Score n/a Close	1